1. Home
  2. PDLB vs PRQR Comparison

PDLB vs PRQR Comparison

Compare PDLB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.90

Market Cap

379.9M

Sector

N/A

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.71

Market Cap

167.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
PRQR
Founded
1960
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
379.9M
167.5M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
PDLB
PRQR
Price
$16.90
$1.71
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$6.80
AVG Volume (30 Days)
60.2K
366.8K
Earning Date
04-24-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
N/A
EPS
1.20
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$18.88
Revenue Next Year
N/A
N/A
P/E Ratio
$13.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.88
$1.08
52 Week High
$18.01
$3.10

Technical Indicators

Market Signals
Indicator
PDLB
PRQR
Relative Strength Index (RSI) 62.22 54.29
Support Level $15.92 $1.33
Resistance Level $17.13 $1.80
Average True Range (ATR) 0.28 0.13
MACD 0.05 -0.00
Stochastic Oscillator 83.72 71.00

Price Performance

Historical Comparison
PDLB
PRQR

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: